Burrill & Co. CEO Steven Burrill said he believes the biotech industry has potential this year even if the health reform law presents financial difficulties for companies. During his speech at the BIO conference, Burrill said he expects more consolidations as large drugmakers face patent expirations and search for revenue growth.

Related Summaries